TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Roche Diagnostics Scandinavia AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
374,195
|
385,593
|
464,106 |
| Financial expenses |
44
|
9
|
12 |
| Earnings before taxes |
11,270
|
12,787
|
16,490 |
| EBITDA |
27,695
|
26,408
|
34,038 |
| Total assets |
169,764
|
169,580
|
187,293 |
| Current assets |
123,362
|
137,706
|
151,361 |
| Current liabilities |
79,345
|
86,230
|
108,431 |
| Equity capital |
87,551
|
81,809
|
78,520 |
| - share capital |
6,045
|
6,014
|
6,544 |
| Employees (average) |
97
|
97
|
105 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
51.6%
|
48.2%
|
41.9% |
| Turnover per employee |
3,858
|
3,975
|
4,420 |
| Profit as a percentage of turnover |
3.0%
|
3.3%
|
3.6% |
| Return on assets (ROA) |
6.7%
|
7.5%
|
8.8% |
| Current ratio |
155.5%
|
159.7%
|
139.6% |
| Return on equity (ROE) |
12.9%
|
15.6%
|
21.0% |
| Change turnover |
-13,384
|
-40,920
|
22,096 |
| Change turnover % |
-3%
|
-10%
|
5% |
| Chg. No. of employees |
0
|
-8
|
4 |
| Chg. No. of employees % |
0%
|
-8%
|
4% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.